Induced Pluripotent Stem Cells in Disease Biology and the Evidence for Their In Vitro Utility

A Adegunsoye, NM Gonzales… - Annual Review of …, 2023 - annualreviews.org
Many human phenotypes are impossible to recapitulate in model organisms or immortalized
human cell lines. Induced pluripotent stem cells (iPSCs) offer a way to study disease …

Genetics and genomics of pulmonary fibrosis: charting the molecular landscape and sha** precision medicine

A Adegunsoye, JA Kropski, J Behr… - American Journal of …, 2024 - atsjournals.org
Recent genetic and genomic advancements have elucidated the complex etiology of
idiopathic pulmonary fibrosis (IPF) and other progressive fibrotic interstitial lung diseases …

[HTML][HTML] Durable alveolar engraftment of PSC-derived lung epithelial cells into immunocompetent mice

MJ Herriges, M Yampolskaya, BR Thapa… - Cell Stem Cell, 2023 - cell.com
Durable reconstitution of the distal lung epithelium with pluripotent stem cell (PSC)
derivatives, if realized, would represent a promising therapy for diseases that result from …

Optimized ACE2 decoys neutralize antibody-resistant SARS-CoV-2 variants through functional receptor mimicry and treat infection in vivo

JA Torchia, AH Tavares, LS Carstensen, DY Chen… - Science …, 2022 - science.org
As severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) evolves to escape
natural antibodies, it also loses sensitivity to therapeutic antibody drugs. By contrast …

[HTML][HTML] Culture impact on the transcriptomic programs of primary and iPSC-derived human alveolar type 2 cells

KD Alysandratos, C Garcia-de-Alba, C Yao, P Pessina… - JCI insight, 2023 - ncbi.nlm.nih.gov
Dysfunction of alveolar epithelial type 2 cells (AEC2s), the facultative progenitors of lung
alveoli, is implicated in pulmonary disease pathogenesis, highlighting the importance of …

Cellular metabolomics of pulmonary fibrosis, from amino acids to lipids

W Roque, F Romero - American Journal of Physiology-Cell …, 2021 - journals.physiology.org
Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive lung disease of unknown
etiology with limited treatment options. It is characterized by repetitive injury to alveolar …

Metabolic reprogramming of pulmonary fibrosis

J Li, X Zhai, X Sun, S Cao, Q Yuan… - Frontiers in …, 2022 - frontiersin.org
Pulmonary fibrosis is a progressive and intractable lung disease with fibrotic features that
affects alveoli elasticity, which leading to higher rates of hospitalization and mortality …

Hyperoxia-induced bronchopulmonary dysplasia: better models for better therapies

K Giusto, H Wanczyk, T Jensen… - Disease Models & …, 2021 - journals.biologists.com
Bronchopulmonary dysplasia (BPD) is a chronic lung disease caused by exposure to high
levels of oxygen (hyperoxia) and is the most common complication that affects preterm …

[HTML][HTML] Air-liquid interface culture promotes maturation and allows environmental exposure of pluripotent stem cell–derived alveolar epithelium

KM Abo, JS de Aja, J Lindstrom-Vautrin… - JCI insight, 2022 - ncbi.nlm.nih.gov
Type 2 alveolar epithelial cells (AT2s), facultative progenitor cells of the lung alveolus, play a
vital role in the biology of the distal lung. In vitro model systems that incorporate human cells …

Senescence of alveolar epithelial progenitor cells: A critical driver of lung fibrosis

T Parimon, P Chen, BR Stripp, J Liang… - … of Physiology-Cell …, 2023 - journals.physiology.org
Pulmonary fibrosis comprises a range of chronic interstitial lung diseases (ILDs) that impose
a significant burden on patients and public health. Among these, idiopathic pulmonary …